openPR Logo
Press release

Biodefense Market Outlook to 2023 - Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeu

12-18-2018 11:17 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Research for Markets

Research For Markets

Research For Markets

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

Get Sample Copy of Report at https://www.researchformarkets.com/sample/global-biodefense-market-85976

Market Segment by Companies, this report covers: Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeutics, Dynavax Technologies,,Cleveland BioLabs Soligenix and Alnylam Pharmaceuticals.

Market Segment by Regions, regional analysis covers

· North America (USA, Canada and Mexico)
· Europe (Germany, France, UK, Russia and Italy)
· Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
· South America (Brazil, Argentina, Columbia etc.)
· Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

· Anthrax
· Smallpox
· Botulism
· Radiation/Nuclear
· Others

Market Segment by Applications, can be divided into

· US Military Market
· US Civilian Market
· Non - US Market

Browse Complete Report at https://www.researchformarkets.com/reports/global-biodefense-market-85976

Table of Content

1 Biodefense Market Overview

2 Manufacturers Profiles
2.1 Emergent Biosolutions
2.1.1 Business Overview
2.1.2 Biodefense Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Emergent Biosolutions Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Hytest
2.2.1 Business Overview
2.2.2 Biodefense Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Hytest Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Biodefense Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Biodefense Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biodefense Market Competition, by Players

4 Global Biodefense Market Size by Regions

5 North America Biodefense Revenue by Countries

6 Europe Biodefense Revenue by Countries

7 Asia-Pacific Biodefense Revenue by Countries

8 South America Biodefense Revenue by Countries

9 Middle East and Africa Revenue Biodefense by Countries

10 Global Biodefense Market Segment by Type

11 Global Biodefense Market Segment by Application

12 Global Biodefense Market Size Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

Place Direct Purchase Order of Biodefense Market at https://www.researchformarkets.com/buy-now/global-biodefense-market-85976/one

Scope of the Report:

· This report focuses on the Biodefense in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

· USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.

· By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.

· In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.

· The worldwide market for Biodefense is expected to grow at a CAGR of roughly 8.5% over the next five years, will reach 1390 million US$ in 2023, from 850 million US$ in 2017, according to a new GIR (Global Info Research) study.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Info:
Name: Research For Markets
Email: alan.naidu@researchformarkets.com
Phone: +44 8000-4182-37

Research For Markets indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East And Africa.

Level 21, Dashwood House
69 Old Broad Street
London EC2M 1QS, United Kingdom

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biodefense Market Outlook to 2023 - Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeu here

News-ID: 1447015 • Views: 518

More Releases from Research for Markets

Fuel Management System Market SWOT analysis and Key Growth methodologies By Gilb …
The Fuel Management System is primarily used as a commercial consumption tool to control, monitor and maintain fuel consumption in many industries that use transportation, including air, rail, road and water. Fuel management systems are basically designed to manage the proper use of fuel and are also used to effectively measure fuel consumption in the construction and transportation industries. Fuel management systems compromise the most comprehensive solution on the global
Superfoods Market Research 2019-2028 on Top Industry Players : Archer Daniels Mi …
The supermarket market is expected to grow globally with a CAGR of 9.5% per annum until 2028. The global superfood market is expected to grow significantly during the forecast period. This may be mainly due to a significant consumer shift to a healthy lifestyle supplemented by the intake of nutritious and healthy foods. Superfoods are described as nutrient-rich foods such as fiber, antioxidants, fatty acids and minerals. These products have
Qualcomm, NEC Corporation, CommScope and Huawei Technologies are Dominating the …
The Wireless Infrastructure Market Research Report is a first-rate research manual that examines the overall market structure, huge drivers, deviations, constraints and opportunities in the wireless infrastructure market. In addition, the development of product drift, critical drivers, difficulties, and market opening are clearly detected and dissected during this report. The market drivers and market restrictions mentioned in this Wireless Infrastructure Report help organizations think about generation methodologies. Stocks of these
Telecom Electronic Manufacturing Services (EMS) Market Projected to Gain Signifi …
The global telecom electronic manufacturing services (EMS) market size is estimated at USD 302.72 billion by 2028. It is expected to register a substantial CAGR of 7.5%. IoT is the next key trend and is estimated to support the telecom industry in terms of revenue generation and infrastructure expansion, which is subsequently estimated to drive the market over the forecast years. This report focuses on the global Telecom Electronic

All 5 Releases


More Releases for Biodefense

Biodefense Market - Real Time Analysis
Biodefense has been advancing, particularly in the U.S., subsequent to the 2001 anthrax attack. The use of biological warfare can be traced back to 1346 A.D. when plaque afflicted human corpses were hurled over the besieged walls of Caffa. Presently, the use of biological warfare is banned following a United Nations convention signed in 1972. However, the absence of verification protocol has not been sufficient to prevent countries from developing
Biodefense Market - Rising Emphasis Of Key Players & Forecast 2015 - 2023
Global Biodefense Market: Overview  Biodefense has been advancing, particularly in the U.S., subsequent to the 2001 anthrax attack. The use of biological warfare can be traced back to 1346 A.D. when plaque afflicted human corpses were hurled over the besieged walls of Caffa. Presently, the use of biological warfare is banned following a United Nations convention signed in 1972. However, the absence of verification protocol has not been sufficient to prevent
Biodefense Market share valued $17bn by 2024
According to research report “Biodefense Market Size By Product (Anthrax, Small Pox, Botulism, Radiation/ Nuclear), Industry Analysis Report, Regional Outlook (U.S., Canada, U.K, Germany, China, Japan, Mexico, Brazil, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., Global Biodefense Market size contribution was $9.8 billion for 2015 with CAGR of 6.91% predicted to be registered for forecast timeline. Rising bioterrorism
Biodefense Market Share 2017-2022 Emergent Biosolutions, Hytest, GSK, Sanofi
Global Biodefense Market Research Report 2012-2022 A recent report discusses the market study on "Biodefense Market" over the global and major regions, from angles of manufacturers, product types and end industries. This “Biodefense Market” research study involved the extensive usage of both primary and secondary data sources, The report on the global Biodefense market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends and market
Biodefense Market share valued $17bn by 2024
According to research report “Biodefense Market Size By Product (Anthrax, Small Pox, Botulism, Radiation/ Nuclear), Industry Analysis Report, Regional Outlook (U.S., Canada, U.K, Germany, China, Japan, Mexico, Brazil, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., Global Biodefense Market size contribution was $9.8 billion for 2015 with CAGR of 6.91% predicted to be registered for forecast timeline. Rising bioterrorism
US Biodefense Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title US Biodefense Market Outlook 2022 to its growing collection of premium market research reports. The dangers posed by the weapons of mass destruction have caught the attention of every nation worldwide. These weapons can be characterized by their potential for large-scale destruction and the indiscriminate nature of their effects, notably against civilians. Increasing threat of biological, chemical as well as nuclear